Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Arrowhead Pharmaceuticals Inc. buy Morgan Stanley

Arrowhead Pharmaceuticals Inc.
Start price
€76.32
23.07.26 / 50%
Target price
€105.00
23.07.27
Performance (%)
-1.31%
Price
€75.32
16:00
Summary
This prediction is currently active. With a performance of -1.31%, the BUY prediction by Morgan_Stanley is trending in the wrong direction. This prediction currently runs until 23.07.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w
Arrowhead Pharmaceuticals Inc. 3.269%
iShares Core DAX® 2.573%
iShares Nasdaq 100 4.858%
iShares Nikkei 225® 5.590%
iShares S&P 500 3.250%

Comments by Morgan_Stanley for this prediction

In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -1.31%
Target price 105.000
Change
Ends at 23.07.27

Arrowhead Pharmaceuticals (ARWR) had its price target raised by Morgan Stanley from $100.00 to $120.00. They now have an "overweight" rating on the stock.
Ratings data for ARWR provided by MarketBeat

Morgan Stanley 
0
Report Share
23.07.26

Stopped prediction by Morgan_Stanley for Arrowhead Pharmaceuticals Inc.

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€61.38
21.04.26
€84.90
21.04.27
22.71%
16:00

Morgan Stanley 
21.04.26 50%